Suprema HQ Inc. (KOSDAQ:094840)
10,000
+220 (2.25%)
At close: Jun 10, 2026
Suprema HQ Revenue
Suprema HQ had revenue of 7.33B KRW in the quarter ending March 31, 2026, with 24.92% growth. This brings the company's revenue in the last twelve months to 22.69B, up 7.79% year-over-year. In the year 2025, Suprema HQ had annual revenue of 21.22B with 5.58% growth.
Revenue (ttm)
22.69B
Revenue Growth
+7.79%
P/S Ratio
3.97
Revenue / Employee
n/a
Employees
n/a
Market Cap
90.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.22B | 1.12B | 5.58% |
| Dec 31, 2024 | 20.10B | -284.67M | -1.40% |
| Dec 31, 2023 | 20.39B | 3.06B | 17.67% |
| Dec 31, 2022 | 17.33B | -13.54B | -43.87% |
| Dec 31, 2021 | 30.87B | 4.61B | 17.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DYPNF Co.,Ltd | 363.17B |
| Hyundai HT Co,Ltd. | 143.93B |
| Daebongls.Co.,Ltd. | 105.19B |
| Meta Biomed | 99.67B |
| HANPASS | 68.38B |
| IMT Co., Ltd. | 39.53B |
| Choong Ang Vaccine Laboratory | 39.19B |
| Rnt-X | 37.27B |